Mattia Cremona

Mattia Cremona has a diverse work experience in the field of biopharma and research. Mattia began their career at San Raffaele Biomedical Science Park as a Fellow from August 2002 to October 2003. Mattia then joined IRCCS Istituto Nazionale dei Tumori Foundation in Milan, Italy as a Fellow from October 2004 to December 2008. After that, they worked at George Mason University as a Postdoctoral Fellow from January 2009 to January 2011. Following this, they became a Research Fellow at RCSI in August 2011. Currently, they hold the position of Director of Biopharma Laboratory at Theralink Technologies, Inc. since November 2022.

Mattia Cremona's education history begins with a Master Degree in Biological Sciences, specializing in Molecular Biology, from the University of Insubria. This degree was earned between the years 1996 and 2002.

After completing the Master's program, Cremona pursued a Master in Bioinformatics at the University of Milan-Bicocca, studying from 2003 to 2004.

Following this, Cremona undertook a PhD in Molecular Medicine at the University of Milan, which spanned from 2006 to 2009.

Most recently, in 2019, Cremona pursued further education by enrolling in the TU Dublin - Innopharma Education, where they completed a Level 8 Higher Diploma in Bio Pharmaceutical and Medical Devices Manufacturing, focusing on Bio Pharmaceutical. This program was completed in 2020.